# HR021618 in Moderate to Severe Pain After Abdominal Surgery

> **NCT04811053** · PHASE2 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Pain After Abdominal Surgery

## Interventions

- **DRUG:** HR021618
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04811053
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-12
- **Primary completion:** 2021-07-15
- **Final completion:** 2021-07-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04811053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04811053, "HR021618 in Moderate to Severe Pain After Abdominal Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04811053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*